Atyr Pharma Inc (NASDAQ:ATYR)’s traded shares stood at 0.67 million during the last session, with the company’s beta value hitting 1.10. At the close of trading, the stock’s price was $3.61, to imply a decrease of -3.73% or -$0.14 in intraday trading. The ATYR share’s 52-week high remains $4.22, putting it -16.9% down since that peak but still an impressive 61.5% since price per share fell to its 52-week low of $1.39. The company has a valuation of $303.03M, with an average of 1.07 million shares in intraday trading volume over the past 10 days and average of 956.08K shares over the past 3 months.

Atyr Pharma Inc (NASDAQ:ATYR) trade information

After registering a -3.73% downside in the last session, Atyr Pharma Inc (ATYR) has traded red over the past five days. The 5-day price performance for the stock is 2.27%, and 19.14% over 30 days. With these gigs, the year-to-date price performance is -0.28%. Short interest in Atyr Pharma Inc (NASDAQ:ATYR) saw shorts transact 3.65 million shares and set a 4.37 days time to cover.

Atyr Pharma Inc (ATYR) estimates and forecasts

Looking at statistics comparing Atyr Pharma Inc share performance against respective industry, we note that the company has underperformed competitors. Atyr Pharma Inc (ATYR) shares are 120.12% up over the last 6 months, with its year-to-date growth rate lower than industry average at 3.19% against 16.60%. The rating firms project that company’s revenue will shrink -56.70% compared to the previous financial year.

ATYR Dividends

Atyr Pharma Inc has its next earnings report out in February. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.

We also have Federated Hermes Kaufmann Fund and Federated Hermes Kaufmann Small Cap Fund as the top two Mutual Funds with the largest holdings of the Atyr Pharma Inc (ATYR) shares. Going by data provided on Oct 31, 2024 , Federated Hermes Kaufmann Fund holds roughly 7.85 shares. This is just over 9.35% of the total shares, with a market valuation of $28.34 million. Data from the same date shows that the other fund manager holds a little less at 6.62, or 7.89% of the shares, all valued at about 23.9 million.